股票代码：688759 股票简称：必贝特 广州必贝特医药股份有限公司 2025年第一次临时股东大会会议资料 2025 年 11 月 | 目录 | | --- | | 2 0 | 2 | 5 | 年 第 | 一 | 次 | 临 | 时 | 股 | 东 | 大 | 会 | 会 | 议 须 | 知 | ------------------------------------------------------- 1 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2 0 | 2 | 5 | 年 第 | 一 | 次 | 临 | 时 | 股 | 东 | 大 | 会 | 会 | 议 议 | 程 | ------------------------------------------------------- 3 | | 2 0 | 2 | 5 | 年 第 | 一 | 次 | 临 | 时 | 股 | 东 | 大 | 会 | 会 | 议 议 | 案 | --------- ...

股票代码：688759 股票简称：必贝特 广州必贝特医药股份有限公司 2025年第一次临时股东大会会议资料 2025 年 11 月 | 目录 | | --- | | 2 0 | 2 | 5年 | 第 一 | 次 | 临 | 时 | 股 | 东 | 大 | 会 | 会 | 议 | 须 知 | | ------------------------------------------------------- 1 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2 0 | 2 | 5年 | 第 一 | 次 | 临 | 时 | 股 | 东 | 大 | 会 | 会 | 议 | 议 程 | | ------------------------------------------------------- 3 | | 2 0 | 2 | 5年 | 第 一 | 次 | 临 | 时 | 股 | 东 | 大 | 会 | 会 | 议 | 议 案 | | ------------ ...

Group 1 - The company Beibete stated that as of November 10, 2025, the number of shareholders is 23,967 [1]

Market Overview - The Sci-Tech Innovation Board (STAR Market) index fell by 1.24%, closing at 1328.19 points, with a total trading volume of 3.128 billion shares and a turnover of 142.69 billion yuan, resulting in a weighted average turnover rate of 1.63% [1] - Among the tradable stocks on the STAR Market, 121 stocks closed higher, with 3 stocks rising over 10% and 13 stocks rising between 5% and 10%. Conversely, 465 stocks closed lower [1] Trading Activity - The distribution of turnover rates for STAR Market stocks shows that 2 stocks had turnover rates exceeding 20%, 8 stocks had rates between 10% and 20%, 43 stocks had rates between 5% and 10%, 54 stocks had rates between 3% and 5%, 305 stocks had rates between 1% and 3%, and 181 stocks had rates below 1% [1] - C Hengkong, a newly listed stock, had the highest turnover rate at 47.40%, closing down by 3.05% with a trading volume of 1.454 billion yuan and a net outflow of 34.016 million yuan in main funds [1] - Other notable stocks include Bibet, which rose by 7.73% with a turnover rate of 21.08%, and several others like Yingfang Software, Huasheng Lithium, and Weidao Nano, with turnover rates of 18.95%, 13.99%, and 13.26% respectively [1] High Turnover Stocks - Among stocks with a turnover rate exceeding 5%, C Hengkong is noted as a newly listed stock. In terms of market performance, 21 stocks in this category rose today, with San Da Membrane, Gongda High-Tech, and Qingyun Technology leading with increases of 13.74%, 10.80%, and 10.76% respectively. Conversely, Huasheng Lithium, Hexin Instruments, and Jindike saw declines of 9.33%, 7.43%, and 6.87% respectively [2] - The electronic industry had the highest representation among high turnover stocks, with 21 stocks, followed by the power equipment and computer sectors with 9 and 5 stocks respectively [2] Fund Flow - In terms of fund flow, 24 stocks in the high turnover category experienced net inflows, with Dekeli, Dongxin Co., and Haibo Sichuang receiving the most significant net inflows of 99.676 million yuan, 86.0429 million yuan, and 66.7609 million yuan respectively. On the other hand, Baiwei Storage, Shijia Photon, and Shijia Technology faced substantial net outflows of 276 million yuan, 141 million yuan, and 135 million yuan respectively [2] - Recent movements in leveraged funds indicate that 33 stocks have seen net purchases of leveraged funds, with Dongxin Co., Huasheng Lithium, and Huafeng Technology showing significant increases in financing balances of 294 million yuan, 261 million yuan, and 227 million yuan respectively. Conversely, Artis, Shijia Photon, and Tengjing Technology experienced notable decreases in financing balances of 136 million yuan, 113 million yuan, and 103 million yuan respectively [3] Key Stocks - The top stocks by turnover rate on November 20 include: - C Hengkong: Closing price 58.22 yuan, daily change -3.05%, turnover rate 47.40%, net outflow -34.016 million yuan [4] - Bibet: Closing price 29.98 yuan, daily change +7.73%, turnover rate 21.08%, net inflow +35.5901 million yuan [4] - Yingfang Software: Closing price 56.00 yuan, daily change +0.90%, turnover rate 18.95%, net inflow +55.9331 million yuan [4] - Huasheng Lithium: Closing price 103.99 yuan, daily change -9.33%, turnover rate 13.99%, net outflow -94.0686 million yuan [4] - Weidao Nano: Closing price 59.12 yuan, daily change -1.63%, turnover rate 13.26%, net outflow -90.0089 million yuan [4]

Group 1 - The company has approved a proposal to change its registered capital and company type, which will be submitted for review at the upcoming shareholders' meeting [1][2] - The company has completed its initial public offering (IPO) of 90 million shares, increasing its total shares from 36,003.6657 million to 45,003.6657 million and its registered capital from 36,003.6657 million RMB to 45,003.6657 million RMB [1][2] - The company type has been changed from a foreign-invested, unlisted joint-stock company to a foreign-invested, listed joint-stock company [1][2] Group 2 - The company is revising its articles of association to enhance operational standards, in accordance with relevant laws and regulations, and will eliminate the supervisory board, transferring its responsibilities to the audit committee [2][3] - The revised articles will be effective upon approval at the shareholders' meeting, and the original articles will be automatically nullified [3] - The company will disclose the revised articles on the Shanghai Stock Exchange website after the shareholders' meeting [3]

Group 1 - The company held the second supervisory board's seventh (temporary) meeting on November 11, 2025, with all three supervisors present, ensuring compliance with relevant laws and regulations [2][3][5] - The supervisory board approved the adjustment of the proposed investment amount for fundraising projects due to the actual net fundraising amount being lower than planned, ensuring no harm to the company or shareholders' interests [3][4][56] - The board also approved the use of temporarily idle fundraising funds for cash management, which is expected to enhance fund utilization efficiency and increase company revenue [7][8][44] Group 2 - The company announced the first temporary shareholders' meeting for 2025, scheduled for November 28, 2025, with a combination of on-site and online voting [17][21][29] - The meeting will discuss previously disclosed proposals, including special resolutions and voting procedures for shareholders [21][22][24] Group 3 - The company plans to use up to RMB 900 million of temporarily idle fundraising funds for cash management, focusing on high-security, liquid financial products [31][33][36] - The cash management aims to improve fund utilization efficiency while ensuring that it does not affect the implementation of fundraising projects [41][44][46] Group 4 - The company intends to use its own funds to pay for fundraising project expenses and subsequently replace them with equivalent amounts from the fundraising account, ensuring operational efficiency [61][64][67] - This approach is designed to comply with the principle of using fundraising funds specifically for their intended purpose and will not affect the normal operation of fundraising projects [67][69][72]

募集资金基本情况 据公告，必贝特于2025年完成首次公开发行股票（IPO），发行股份数量为9000.00万股，发行价格 17.78元/股，募集资金总额160,020.00万元，扣除发行费用（不含增值税）后，募集资金净额为 149,114.31万元（约14.91亿元）。该募集资金到位情况已由中审众环会计师事务所审验，并出具《验资 报告》。目前，公司已与保荐人及商业银行签订募集资金专户监管协议，实行专户储存管理。 募投项目概况 根据调整后方案，必贝特本次募集资金将投向三大募投项目，总投资金额达200,460.91万元（约20.05亿 元），具体如下： 单位：万元 项目名称 项目总投资 调整后拟投入募集资金金额 调整前拟投入募集资金金额 新药研发项 目 94,912.34 94,912.34 70,601.24 清远研发中心及制剂产业化基地建设项目 55,548.57 55,548.57 41,320.21 补充流动资金 50,000.00 50,000.00 37,192.86 合计 200,460.91 200,460.91 149,114.31 置换原因及操作流程 置换原因 公告指出，本次以自有资金先行支付的 ...

广州必贝特医药股份有限公司 对外担保管理制度 第一章 总则 第一条 为了规范广州必贝特医药股份有限公司（以下简称"公司"）的对 外担保行为，有效控制公司对外担保风险，保护公司和全体股东合法权益和公司 财务安全，根据《中华人民共和国公司法》《中华人民共和国民法典》（以下简 称"《民法典》"）《上海证券交易所科创板股票上市规则》等法律、法规、规 范性文件以及《广州必贝特医药股份有限公司章程》（以下简称"《公司章程》"） 等有关规定，制定本制度。 第二条 本制度所称对外担保是指公司为他人提供的担保（包括保证、抵押 或质押等），包括公司对控股子公司提供的担保。 公司及公司控股子公司的对外担保总额，是指包括公司对控股子公司在内的 公司对外担保总额与控股子公司对外担保总额之和。 公司控股子公司或公司具有实际控制权的参股子公司的对外担保，视同公司 行为，其对外担保应执行本制度。 第三条 公司为他人提供担保应当遵循合法、审慎、互利、安全、自愿、诚 信的原则，严格控制担保风险。 第四条 公司对外担保实行统一管理，未经公司董事会或股东会批准，公司 及控股子公司不得对外提供担保，任何人无权以公司名义签署对外担保的合同、 协议或其他 ...

广州必贝特医药股份有限公司 章程 二〇二五年十一月 1 | | | 广州必贝特医药股份有限公司 章程 第一章 总则 第一条 为维护广州必贝特医药股份有限公司（以下简称"公司"）、股 东和债权人的合法权益，规范公司的组织和行为，根据《中华人民共和国公司 法》（以下简称"《公司法》"）、《中华人民共和国证券法》、和其他有关 规定，制订本章程。 第二条 公司系依照《公司法》和其他有关规定成立的股份有限公司。 公司系在广州必贝特医药技术有限公司的基础上，依法整体变更设立的股份 有限公司，在广州市市场监督管理局注册登记，取得营业执照，统一社会信用代 码为 91440101589519277H。 公司于 2025 年 8 月 4 日经中国证券监督管理委员会（以下简称"中国证监 会"）同意注册，首次向社会公众发行人民币普通股 9,000 万股，于 2025 年 10 月 28 日在上海证券交易所上市。 第三条 公司注册名称：广州必贝特医药股份有限公司。 英文名称：BeBetter Med Inc. 第四条 公司住所：广州市高新技术产业开发区科学城崖鹰石路 25 号 A-3 栋第八层 802 房，邮政编码：510663。 第 ...

广州必贝特医药股份有限公司 独立董事工作制度 为进一步完善广州必贝特医药股份有限公司（以下简称"公司"）治理结构， 促进公司规范运作，根据《中华人民共和国公司法》（以下简称"公司法"）《中 华人民共和国证券法》（以下简称"《证券法》"）《上海证券交易所科创板股 票上市规则》（以下简称"《科创板上市规则》"）《上市公司独立董事管理办 法》等法律法规、规范性文件以及《广州必贝特医药股份有限公司章程》（以下 简称"《公司章程》"），特制定本制度。 第一章 总则 第一条 本制度所指的独立董事，是指不在公司担任除董事外的其他职务， 并与公司及其主要股东、实际控制人不存在直接或者间接利害关系，或者其他可 能妨碍其进行独立客观判断的关系的董事。 独立董事应当独立履行职责，不受公司及其主要股东、实际控制人等单位或 者个人的影响。 第二条 独立董事对公司及全体股东负有忠实与勤勉义务。独立董事应当按 照法律、行政法规、中国证券监督管理委员会（以下简称"中国证监会"）规定、 证券交易所业务规则和公司章程的规定，认真履行职责，在董事会中发挥参与决 策、监督制衡、专业咨询作用，维护上市公司整体利益，保护中小股东合法权益。 第三条 公司 ...